rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Eloxx Pharmaceuticals, Inc.

ELOX · Nasdaq

Health CareBiotechnology

We hold no 150-day reading for ELOX yet: it needs about 200 sessions of history. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation
not in the set
Weeks in an uptrend
—
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
22

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders22
New · exited22 · 0
Reported value$35.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Stonepine Capital Management, LLCnew · filed 14 Aug 2026447,160$6.2M+447,160
Nantahala Capital Management, LLCnew · filed 14 Aug 2026400,000$5.6M+400,000
EcoR1 Capital, LLCnew · filed 14 Aug 2026400,000$5.6M+400,000
Aberdeen Group plcnew · filed 31 Jul 2026400,000$5.6M+400,000
SAMSARA BIOCAPITAL, LLCnew · filed 14 Aug 2026400,000$5.6M+400,000
Siren, L.L.C.new · filed 13 Aug 2026400,000$5.6M+400,000
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 202678,680$1.1M+78,680
VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 202610,602$147K+10,602
SEVEN GRAND MANAGERS, LLCnew · filed 14 Aug 202610,000$139K+10,000
MORGAN STANLEYnew · filed 13 Aug 20261,544$21K+1,544
31 Mar 2023 – 30 Jun 2026
11121Mar 23Sep 23Mar 24Jun 24Jun 26

News

No headline names it lately.

Everyone who traded it

Domicilium Real Estate Fund III LP Company insider10% owner · last 10 Jun 20260 · 0
Sumit Aggarwal Company insiderPresident and CEO · last 10 Jun 20260 · 0
Alan Edmund Walts Company insiderDirector · last 8 Jun 20260 · 0
Nina S. Kjellson Company insiderDirector · last 8 Jun 20260 · 0
Stephen W. Webster Company insiderDirector · last 8 Jun 20260 · 0
Steven D. Rubin Company insiderDirector · last 8 Jun 20260 · 0
Coastlands Capital LP Company insider10% owner · last 27 May 20260 · 0
Lindsay Androski Company insiderDirector · last 24 Jan 20250 · 0
Tomer Kariv Company insiderDirector · last 30 Jan 20235 · 0
Vijay Modur Company insiderHEAD OF R&D · last 25 Jan 20230 · 0
Gadi Veinrib Company insiderDirector · last 15 Jun 20220 · 0
Jasbir Seehra Company insiderDirector · last 15 Jun 20220 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 12 Mar 20265.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$4.8M

Analyst forecasts

No analyst forecasts yet.